ArticleScientific reports2025
Antibiofilm activity of cationic carbosilane BD132 dendron and its synergistic effect with amphotericin B against Candida spp.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of the BD132 Dendron AgainstPharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The BD132 is a cationic carbosilane dendron containing peripheral ammonium groups, which impairs antimicrobial properties, and the chaperone 4-phenylbutyrate, with anti-inflammatory and antibacterial properties. Its in vitro activity was evaluated against biofilm formation and against established biofilms in Candida albicans and Nakaseomyces glabratus (former named Candida glabrata). In addition, the BD132 dendron was used in combination with amphotericin B against both species. Its cytotoxicity was evaluated using HeLa cells. Our data showed that BD132 dendron was an excellent compound that prevented biofilm formation. The Minimum Biofilm Inhibitory Concentration was 16 mg/L for N. glabratus and 32 mg/L for C. albicans, both concentrations were not cytotoxic. Furthermore, in the studies against established biofilms, the dendron was effective eradicating them. Experiments showed that the combination of the dendron with amphotericin B improved the activity of both by reducing the effective concentration of both compounds required to obtain the same results as when used individually. Therefore, the BD132 dendron is a very interesting compound that exhibits low cytotoxicity at active concentrations that prevent the formation of biofilms of these microorganisms. In addition, these results suggest that the BD132 dendron may have great benefits in the development of antifungal agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.